14 research outputs found

    Median and IQR monthly gross ingredient costs of nicotine replacement therapy prescribed in Scotland (2003–2009).

    No full text
    <p>Median and IQR monthly gross ingredient costs of nicotine replacement therapy prescribed in Scotland (2003–2009).</p

    Observed and predicted monthly gross ingredient costs of nicotine replacement therapy prescribed in Scotland (2003–2009).

    No full text
    <p>Observed and predicted monthly gross ingredient costs of nicotine replacement therapy prescribed in Scotland (2003–2009).</p

    Observed and expected monthly gross ingredient costs of nicotine replacement therapy prescribed in Scotland (2003–2009).

    No full text
    <p>Observed and expected monthly gross ingredient costs of nicotine replacement therapy prescribed in Scotland (2003–2009).</p

    Observed and predicted quarterly smoking prevalence in Scotland (January 1999–September 2010).

    No full text
    <p>Observed and predicted quarterly smoking prevalence in Scotland (January 1999–September 2010).</p

    Time series regression analyses of monthly nicotine replacement therapy gross ingredient costs.

    No full text
    <p>*Adjusted for change at March 2006 effect, post March 2006 decay effect, and January/February 2006 peaks.</p><p>**Derived from autoregressive moving average model.</p><p>CI confidence interval; AIC Akaike Information Criterion; RMSE root mean square error.</p

    Time series regression analyses of quarterly smoking prevalence.

    No full text
    <p>*Adjusted for change at March 2006 effect, and post March 2006 decay effect.</p><p>**Derived from autoregressive moving average model.</p><p>CI confidence interval; AIC Akaike Information Criterion; RMSE root mean square error.</p
    corecore